A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
- 2 December 1999
- journal article
- review article
- Published by Elsevier
- Vol. 1489 (1) , 69-84
- https://doi.org/10.1016/s0167-4781(99)00140-2
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 MiceAntisense and Nucleic Acid Drug Development, 1997
- Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12Clinical Immunology and Immunopathology, 1997
- Histological Localization of Phosphorothioate Oligodeoxynucleotides in Normal Rodent TissueNucleosides and Nucleotides, 1997
- Pharmacokinetic Properties of Phosphorothioate OligonucleotidesNucleosides and Nucleotides, 1997
- Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley ratsToxicology, 1997
- Phosphorothioate antisense oligodeoxynucleotides: questions of specificityTrends in Biotechnology, 1996
- Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotideInternational Journal of Immunopharmacology, 1996
- Renal uptake of an 18-mer phosphorothioate oligonucleotideKidney International, 1995
- Antisense inhibition ofEngrailed genes in mouse embryos reveals roles for these genes in craniofacial and neural tube developmentTeratology, 1995
- Antisense targeting of Engrailed‐1 causes abnormal axis formation in mouse embryosTeratology, 1995